Evidence mapPaperPMID 41554990Full record

ArticleCommunications biology2026

Multi-omic analysis of human PHACTR1 signaling networks.

Kathryn Wolhuter, Lijiang Ma, Nicole S Bryce, Osvaldo Contreras, Natalie Mellett, Ling Zhong, Chris Thekkedam, Siiri E Iismaa, Corey Giles, Richard P Harvey and 6 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kathryn WolhuterVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-6293-9820
Lijiang MaZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nicole S BryceVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-9799-7393
Osvaldo ContrerasVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-8722-9371
Natalie MellettBaker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Ling ZhongBioanalytical Mass Spectrometry Facility, University of New South Wales, Sydney, NSW, Australia.
Chris ThekkedamVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-3106-5080
Siiri E IismaaVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-2409-7356
Corey GilesBaker Heart and Diabetes Institute, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-6050-1259
Richard P HarveyVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-9950-9792
Thomas HennessyAgilent Technologies, Mulgrave, VIC, Australia.
Chris FouracreAgilent Technologies, Mulgrave, VIC, Australia.ORCID http://orcid.org/0009-0006-9998-7045
David BradleyAgilent Technologies, Mulgrave, VIC, Australia.
Peter J MeikleBaker Heart and Diabetes Institute, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-2593-4665
Johan L M BjörkegrenZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Jason C KovacicVictor Chang Cardiac Research Institute, Sydney, NSW, Australia. j.kovacic@victorchang.edu.au.ORCID http://orcid.org/0000-0003-4555-769X

Funding

Department of Education and Training | Australian Research Council (ARC) DP210102134Department of Health | National Health and Medical Research Council (NHMRC) 2008743Fondation Leducq 25CVD02NSW Ministry of Health (NSW Health) RG194194
6 · The paper itself

Abstract

Genetic studies have linked PHACTR1 to a range of vascular diseases, underscoring its pivotal role in vascular biology. However, the full spectrum of PHACTR1-mediated signaling pathways remains largely unexplored. To bridge this gap, we employ a multi-omics pipeline combining pairwise differential expression analysis, multi-omics pathway integration, and feature-level correlation analyses across four distinct omics datasets to map the global signaling networks driven by PHACTR1. By integrating transcriptomic, proteomic, metabolic, and lipidomic profiles from human HT1080 cells with PHACTR1 overexpression or knockdown, and then validating key findings in primary human endothelial cells, here we show that PHACTR1 exerts broad control over fundamental cellular processes beyond cytoskeletal regulation. We demonstrate that PHACTR1 governs cell cycle progression, validating that increased expression alters key regulatory proteins. We also uncover a distinct function in iron metabolism, showing PHACTR1 regulates essential cellular iron-storage proteins and identify the PHACTR1 protein within the mitochondria where it directs morphology and bioenergetics through a signaling axis involving AKAP1 and Drp1. These mitochondrial changes align with observed shifts in lipid metabolism and correlations in human arterial tissue. These findings provide a systems-level blueprint of PHACTR1 function, revealing how this gene influences vascular health and offering potential targets for therapeutic intervention.

Indexed as

Microfilament ProteinsSignal TransductionEndothelial CellsGene Expression ProfilingHumansMitochondriaMultiomicsProteomicsMicrofilament Proteins

Identifiers

PMID41554990
PMCPMC12913993

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.